Urinary Biomarker Analysis of the SANCTUARY Trial : Insights into IgA Nephropathy Pathophysiology and Ravulizumab Mechanism of Action.
- DOI
- 10.2215/cjn.0000001243
- Published
- 2026 Oct 22
- Container
- Clinical journal of the American Society of Nephrology : CJASN
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2215/cjn.0000001243,
title = {Urinary Biomarker Analysis of the SANCTUARY Trial : Insights into IgA Nephropathy Pathophysiology and Ravulizumab Mechanism of Action.},
author = {Cammett TJ and Millman EE and Luna J and Rice K and Nolan S and Farag YMK and Lafayette R and Barratt J},
year = {2026},
journal = {Clinical journal of the American Society of Nephrology : CJASN},
doi = {10.2215/cjn.0000001243},
url = {https://doi.org/10.2215/cjn.0000001243}
}RIS
TY - JOUR TI - Urinary Biomarker Analysis of the SANCTUARY Trial : Insights into IgA Nephropathy Pathophysiology and Ravulizumab Mechanism of Action. AU - Cammett TJ AU - Millman EE AU - Luna J AU - Rice K AU - Nolan S AU - Farag YMK AU - Lafayette R AU - Barratt J PY - 2026 JO - Clinical journal of the American Society of Nephrology : CJASN DO - 10.2215/cjn.0000001243 UR - https://doi.org/10.2215/cjn.0000001243 ER -
APA
TJ, C., EE, M., J, L., K, R., S, N., YMK, F., R, L., & J, B. (2026). Urinary Biomarker Analysis of the SANCTUARY Trial : Insights into IgA Nephropathy Pathophysiology and Ravulizumab Mechanism of Action.. Clinical journal of the American Society of Nephrology : CJASN. https://doi.org/10.2215/cjn.0000001243
Source records
- pubmed · retrieved 2026-11-10T07:04:50.430Z